Full title: Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

Author/creator: Shaw, Alice T, Dr, Kim, Tae Min, MD, Crinò, Lucio, Prof, Gridelli, Cesare, MD, Kiura, Katsuyuki, MD, Liu, Geoffrey, MD, Novello, Silvia, Prof, Bearz, Alessandra, MD, Gautschi, Oliver, MD, Mok, Tony, Prof, Nishio, Makoto, MD, Scagliotti, Giorgio, Prof, Spigel, David R, MD, Deudon, Stéphanie, PharmD, Zheng, Cheng, PhD, Pantano, Serafino, PhD, Urban, Patrick, MD, Massacesi, Cristian, MD, Viraswami-Appanna, Kalyanee, PhD, Felip, Enriqueta, MD.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1914872775

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1914872775